Drugs Controller General of India (DCGI)
DCGI grants restricted EUA to Covid jab Corbevax for 12-18 age group
the government has not taken a decision yet on vaccinating those aged below 15 years
Two COVID vaccines may cost Rs. 275 after market nod
The National Pharmaceutical Pricing Authority (NPPA) has already been directed to start working towards capping the price
As COVID cases rise, govt gives nod to two more vaccines, anti-viral pill
With this approval, the number of Covid-19 vaccines which have received emergency use authorisation in the country has risen to eight
CDSCO seeks more data from SII, says Covovax not yet approved in country of origin
The DCGI office had granted SII permission to manufacture and stock Covovax on May 17
AA Edit | Validation glimmer for Covaxin, hope for parents
The two-dose vaccine will be administered with a gap of 28 days
ZyCoV-D to be introduced in Covid vaccination drive shortly: Govt
ZyCoV-D has received the Emergency Use Authorisation from the Drugs Controller General of India (DCGI)
Zydus Cadila's Covid vaccine ZyCoV-D gets approval for Emergency Use Authorisation
ZyCoV-D has become the first vaccine to be administered to those in the age group of 12-18 years in the country
Emergency approval for Zydus Cadila to take few more days, say sources
ZyCoV-D is a DNA Covid vaccine, which carries the genetic code for that part of a virus that triggers the immune system of the body
DGCI likely to approve Moderna's Covid vaccine in India for emergency use
Moderna's vaccine already has been cleared for emergency use by the FDA and regulators in numerous other countries
Biophore applies to DCGI for emergency-use approval for COVID treatment drug
The company plans to commence commercial production of the product immediately after the approval is received